SCHEMBL14453584

SCHEMBL14453584

Cc1cc(C(F)(F)F)ccc1N1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 4/20 0.55
▸ MAPT P10636 4/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ HPGD P15428 1/20 0.47
▸ LMNA P02545 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ ENPP2 Q13822 1/20 0.47
▸ TACR1 P25103 1/20 0.47
▸ PDK2 Q15119 1/20 0.47
▸ TP53 P04637 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ STS P08842 1/20 0.46
▸ MC4R P32245 1/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ SMARCA2 P51531 1/20 0.45
▸ SMARCA4 P51532 1/20 0.45
▸ PBRM1 Q86U86 1/20 0.45
▸ TSHR P16473 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19385731 0.91 MAPT (0.54) GPR119MAPTSMN1; SMN2HPGDLMNA
SCHEMBL3922455 0.88 GPR119 (0.69) GPR119MAPTSMN1; SMN2LMNAALDH1A1
SCHEMBL3923112 0.88 GPR119 (0.54) GPR119MAPTHPGDLMNAALDH1A1
SCHEMBL31142873 0.88 GPR119 (0.69) GPR119MAPTSMN1; SMN2LMNAALDH1A1
SCHEMBL4422111 0.88 GPR119 (0.54) GPR119MAPTSMN1; SMN2HPGDLMNA
SCHEMBL13076730 0.87 GPR119 (0.53) GPR119MAPTSMN1; SMN2HPGDLMNA
SCHEMBL114538 0.87 ALDH1A1 (0.54) GPR119MAPTSMN1; SMN2HPGDLMNA
SCHEMBL115105 0.87 GPR119 (0.53) GPR119MAPTSMN1; SMN2HPGDLMNA
SCHEMBL30301736 0.87 ALDH1A1 (0.54) GPR119MAPTSMN1; SMN2HPGDLMNA
SCHEMBL5913300 0.85 MAPT (0.55) GPR119MAPTSMN1; SMN2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070161677-A1 Bisarylurea derivatives MERCK PATENT GMBH (DE) 2007-07-12 — — US disclosed
US-20070161677-A1 Bisarylurea derivatives MERCK PATENT GMBH (DE) 2007-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161677-A1 Bisarylurea derivatives BRAF, RAF1, NRAS GPR119 1474/4885MAPT 2288/4885SMN1; SMN2 4056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback